The document discusses emerging technology trends and high-potential startups. It profiles several startups working in areas like neurotechnology, regenerative medicine, synthetic animal products, synthetic agriculture, AI chips, and more. These startups are developing technologies to treat chronic pain, help paralyzed patients control devices, 3D print organs, grow meat and leather without animals, improve crop yields, and more. The document also lists top investors in these game-changing companies.
Amazing Breakthrough Technologies That Can Potentially Change the WorldMarie Weaver
A breakthrough is not actually breaking through something and coming out with something never seen or imagined. A breakthrough is the byproduct of multiple innovations combined into one big evolution. Evolution in any medium of our lives takes place when multiple small innovations, experiments, and discoveries combined together to create a new, never before seen feature or a product that leverages our existing lives.
While many companies are contributing to the battle against the pandemic, Deep Tech startups are trying to overcome scientific challenges to help with prevention, testing or treatment in novel and scalable ways.
This live event organized by SOSV brings together investors who have backed dozens of relevant startups, to get a sense of:
- The variety of solutions being developed,
- Their potential outcomes,
- The broader role and opportunities of deep tech investment.
SPEAKERS
- Seth Bannon, Founding Partner, Fifty Years
- Jun Axup, PhD, Chief Science Officer & Partner, IndieBio / SOSV
- Alex Morgan, MD PhD, Partner, Khosla Ventures
MODERATORS
- Julie Wolf, PhD, Communications Director, IndieBio / SOSV
- Benjamin Joffe, Partner, SOSV
COVID-19 PORTFOLIO
- Fifty Years: www.fifty.vc/covid
- SOSV: www.sosv.com/covid-startups/
- Khosla Ventures: www.khoslaventures.com/khosla-ventures-entrepreneurs-are-responding-with-amazing-diversity-to-covid-19-solutions-for-societys-needs
This document lists various AI startups in healthcare and their funding amounts. It describes what each company does, such as using AI for drug discovery, medical imaging analysis, disease detection, and more. The top 3 funded companies are Babylon Health ($635.3M), Zymergen ($574.1M), and Freenome ($507.6M). In total, over 60 AI healthcare startups are mentioned from around the world.
Katalyst Securities is a private equity/venture investment bank that specializes in growth capital and expansion stage investments in technology and healthcare. They source investment opportunities through a global network and partner with venture capital firms. Their goal is to identify innovative ideas, help bring them to life, create brands with long-term value, and drive successful results for portfolio companies and investors. They focus on transactions like private placements, alternative public offerings, and venture capital. Katalyst aims to achieve return on investment for entrepreneurs, high net worth individuals, family offices, and Swiss banks.
According to our recently published Game Changers 2020 report, we look at unique tech categories like speed-of-light chips, mind-altering medicines, and quantum cryptography.
You can read the full report, which highlights the following:
• 200 unique investors backed this year's game changers
• 20 investors backed multiple game changers
• 23 game changer companies are based in the U.S
The Amazing Ways Artificial Intelligence Is Transforming Genomics and Gene Ed...Bernard Marr
It is predicted that artificial intelligence (AI) will transform many aspects of our life including healthcare and genomics. AI and machine learning have helped us to understand the genome of organisms and will potentially change the way we treat disease, determine effective drugs and edit genes.
Jorge Juan Fernández discusses collaboration in digital healthcare using exponential technologies. He notes that healthcare is the only industry where all exponential technologies like smartphones, virtual and augmented reality, 3D printing, artificial intelligence, and sensors are converging. However, barriers to adoption include humans becoming disillusioned as technology advances exponentially, technology not translating to increased productivity, and legacy systems being slow to change. Fernández provides resources on exponential technologies from Singularity University.
Amazing Breakthrough Technologies That Can Potentially Change the WorldMarie Weaver
A breakthrough is not actually breaking through something and coming out with something never seen or imagined. A breakthrough is the byproduct of multiple innovations combined into one big evolution. Evolution in any medium of our lives takes place when multiple small innovations, experiments, and discoveries combined together to create a new, never before seen feature or a product that leverages our existing lives.
While many companies are contributing to the battle against the pandemic, Deep Tech startups are trying to overcome scientific challenges to help with prevention, testing or treatment in novel and scalable ways.
This live event organized by SOSV brings together investors who have backed dozens of relevant startups, to get a sense of:
- The variety of solutions being developed,
- Their potential outcomes,
- The broader role and opportunities of deep tech investment.
SPEAKERS
- Seth Bannon, Founding Partner, Fifty Years
- Jun Axup, PhD, Chief Science Officer & Partner, IndieBio / SOSV
- Alex Morgan, MD PhD, Partner, Khosla Ventures
MODERATORS
- Julie Wolf, PhD, Communications Director, IndieBio / SOSV
- Benjamin Joffe, Partner, SOSV
COVID-19 PORTFOLIO
- Fifty Years: www.fifty.vc/covid
- SOSV: www.sosv.com/covid-startups/
- Khosla Ventures: www.khoslaventures.com/khosla-ventures-entrepreneurs-are-responding-with-amazing-diversity-to-covid-19-solutions-for-societys-needs
This document lists various AI startups in healthcare and their funding amounts. It describes what each company does, such as using AI for drug discovery, medical imaging analysis, disease detection, and more. The top 3 funded companies are Babylon Health ($635.3M), Zymergen ($574.1M), and Freenome ($507.6M). In total, over 60 AI healthcare startups are mentioned from around the world.
Katalyst Securities is a private equity/venture investment bank that specializes in growth capital and expansion stage investments in technology and healthcare. They source investment opportunities through a global network and partner with venture capital firms. Their goal is to identify innovative ideas, help bring them to life, create brands with long-term value, and drive successful results for portfolio companies and investors. They focus on transactions like private placements, alternative public offerings, and venture capital. Katalyst aims to achieve return on investment for entrepreneurs, high net worth individuals, family offices, and Swiss banks.
According to our recently published Game Changers 2020 report, we look at unique tech categories like speed-of-light chips, mind-altering medicines, and quantum cryptography.
You can read the full report, which highlights the following:
• 200 unique investors backed this year's game changers
• 20 investors backed multiple game changers
• 23 game changer companies are based in the U.S
The Amazing Ways Artificial Intelligence Is Transforming Genomics and Gene Ed...Bernard Marr
It is predicted that artificial intelligence (AI) will transform many aspects of our life including healthcare and genomics. AI and machine learning have helped us to understand the genome of organisms and will potentially change the way we treat disease, determine effective drugs and edit genes.
Jorge Juan Fernández discusses collaboration in digital healthcare using exponential technologies. He notes that healthcare is the only industry where all exponential technologies like smartphones, virtual and augmented reality, 3D printing, artificial intelligence, and sensors are converging. However, barriers to adoption include humans becoming disillusioned as technology advances exponentially, technology not translating to increased productivity, and legacy systems being slow to change. Fernández provides resources on exponential technologies from Singularity University.
Transformative Tech, NeuroTech, and Biohacking - Fundraising in 2020 and 2021 Wesley King
Market size and overview from health technology, wellness services, mental health applications, and telehealth solutions. Fundraising advice for first-time entrepreneurs. Call to action to VCs and Family Offices to consider investments in the next generation of impactful health devices. Wesley King @biohackingbanker CEO, Coherent Capital (www.coherentcap.com)
Top 10 companies using CRISPR technologyARUNPANDIAN07
The revolutionary gene editing tool CRISPR/Cas9 has reached its height because of its accuracy and easy-to-design. Several gene corrections have been made by scientists in vitro and in vivo.
For more information, visit, www.theblackchalk.com
Cell Therapy Industry News Round-Up - September 13, 2022 [BioInformant]BioInformant
The document discusses several topics related to stem cells and regenerative medicine:
1) It provides an overview of 10 scientists nominated for a $100,000 stem cell research grant to be awarded in October.
2) It describes a new collaboration between RoosterBio and AGC Biologics to accelerate manufacturing of cell and exosome therapies.
3) It announces that Steakholder Foods will begin developing cultured pork products using induced pluripotent stem cells.
Medical device companies are looking to emerging markets like India, China, Brazil and Russia for growth due to challenges in developed markets from the global financial crisis. The emerging markets offer major opportunities due to their growing economies, expanding middle class populations and increasing healthcare spending. However, to successfully launch devices in these markets, companies will need to understand the local market needs, create customized and affordable products for each market, develop new collaborative R&D networks to drive innovation, and partner with local players to better serve customers.
American CryoStem Corporation was founded in 2008 to standardize adipose tissue-derived stem cell technologies. It operates FDA-registered clinical laboratories in New Jersey, Hong Kong, and Japan. The company leverages its intellectual property portfolio and clinical platform to create a global network of licensed laboratories, physicians, patients, and researchers. Its products include adult stem cells derived from adipose tissue and characterized for regenerative medicine applications. The company focuses on collaborations to discover, develop, and commercialize new adipose-derived stem cell products and applications.
American CryoStem Corporation was founded in 2008 to standardize adipose tissue-derived stem cell technologies. It operates FDA-registered clinical laboratories in New Jersey, Hong Kong, and Japan. The company leverages its intellectual property portfolio and stem cell products to create a global network of licensed laboratories, physicians, patients, and researchers. Its research focuses on collaborations to discover, develop, and commercialize adipose-derived stem cell products and applications in regenerative medicine.
American CryoStem Corporation is a biotechnology company founded in 2008 that operates FDA-registered clinical laboratories. It has developed a proprietary platform and portfolio of intellectual property focused on collecting, processing, storing, and differentiating adipose tissue and adipose-derived stem cells for regenerative medicine applications. The company's products and services are aimed at allowing individuals to prepare for their current or future regenerative medicine needs by storing their stem cells when they are young and healthy.
An Opportunity for delegates to know how much they really know / need to know . The first person who answers a question correctly will get a prize. 30 Minutes of action
packed intellectual treat to find out the smartest !
AI – Opportunities and Challenges in Transforming the Biopharma Value ChainEY
These slides were presented by Pamela Spence, EY Global Life Sciences Industry Leader, at the annual BIO International Convention on 20 June 2017. Pamela led a panel discussion on Artificial Intelligence (AI) and the opportunities and challenges it presents in transforming the biopharma value chain. The panelists included Dr. Attul Butte, Director of the Institute for Computational Health Science at the University of California – San Francisco, Iya Khalil, Chief Commercial Officer and Co-founder of GNS Healthcare, Nathan Price, Associate Director of the Institute for Systems Biology and co-founder of Arivale, and Jackie Hunter, CEO of Benevolent AI
Life Sciences De-Mystified - Mark Bünger - PICNIC '10PICNIC Festival
This document provides an overview of synthetic biology and its potential applications presented by Mark Bünger of Lux Research. It begins with a brief introduction of Lux Research and their focus on emerging technologies. It then provides a high-level introduction to biology, including DNA, proteins, and how cells communicate. Applications of synthetic biology discussed include using biomass to replace petroleum products, standardizing biological parts for predictable circuits, and rapidly declining DNA sequencing costs enabling new products. Corporations, venture capital investment, and biohackers participating in synthetic biology are also mentioned. The document concludes by discussing participating in shaping the future of this emerging field through learning, action, and teaching.
5 companies in the wound healing market to watch for in 2019Avi Surana
The global wound healing market is projected to reach USD 42,069 million by 2024 growing at a CAGR of 6.2%, according to ResearchAndMarkets.com. North America is the largest market for wound care, with U.S alone taking a lion’s share of 38.5% in 2017 while Asia-Pacific is the fastest growing market.
We take a look at some of the companies that are developing novel technologies to address the unmet and growing needs of the wound care market.
ImmunoPrecise Antibodies Ltd (NASDAQ-IPA) Stock In Focus After Latest NewsThe Street Reports
If you are currently looking into artificial intelligence driven innovative companies then you could consider taking a look at ImmunoPrecise Antibodies Ltd (NASDAQ:IPA).
Dr. Jeanann Boyce gave a presentation on current issues in biotechnology and the ethical questions they raise. She discussed three areas: intelligent machines like robots and expert systems; disembodied and distributed intelligence on the internet; and human/machine interfaces like implants, prosthetics and cyborgs. She questioned where to draw the line between human and machine, and who would decide what kinds of part-human creatures or enhanced humans would be developed.
The document discusses various applications of artificial intelligence including in business, healthcare, robotics, and video games. It provides details on how AI is used in industries like online customer support, smart home devices, medical diagnosis and treatment, and remote-controlled or autonomous robots. Examples are given of AI systems developed by companies like Google, IBM, Amazon, and startups for applications such as predictive healthcare analytics, medical data mining, and assisting physicians.
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
Artificial intelligence in field of pharmacyKaustav Dey
AI is a program designed to produce outcome in a manner similar to human intelligence,logic and reasoning.This can be used in field of Pharmacy for betterment of humankind, to save lives,money and time
This document discusses investing in emerging healthcare technologies that could save lives in the future. It notes that diseases like kidney disease, influenza, diabetes, Alzheimer's, respiratory diseases, stroke and cancer caused over 3 million deaths in the US in 2020. The document then profiles several companies in Zoic Capital's portfolio that are developing technologies like Raman spectroscopy probes for cancer detection, retina scanning for early Alzheimer's detection, bioelectronic probes, RNA vaccines, at-home genetic testing, brain stimulation for mental health conditions, and more. It argues these emerging technologies could transform healthcare delivery by lowering costs, improving quality and access to care.
The document describes a decentralized smart collaborative IT platform that aims to become a collective human general intelligence, rather than an artificial general intelligence. It will harness expertise from around the world, regardless of nationality, and use ratings and voting to ensure objectivity. Experts will confirm the competence of start-up projects, and investors can find inexpensive expertise. The system was created by Deep Knowledge Ventures to access the best scientific ideas, and will become self-sufficient over time.
Artificial Intelligence Service in HealthcareAnkit Jain
It is no secret that artificial intelligence is shaping new business landscapes in every industries. As one of emerging convergence technologies, Artificial Intelligence (AI) creates new products and services, finally innovating business models. Especially, it has been noted by industry experts and researchers that healthcare sector has the biggest potential of AI convergence. In fact, major technology companies including Google, Microsoft and IBM have invested in AI in healthcare sector. Thousands of AI startups are active launching innovative services related to healthcare.
Quantitative + Qualitative = User Behavior Analytics
Introducing REAL User Behavior Analytics to your product team to better understand what and how users use your online/mobile applications.
7 Key Principles Designing for VUI/CUI
1. Onboarding the user & help them get started
2. Keep conversation exchanges brief to reduce cognitive load.
3. Examples work better than instructions.
4. Delight without interfering with the tasks.
5. Use explicit confirmation for important actions, & implicit for less risky.
6. Design for failure.
7. Respect the user's privacy and security.
Transformative Tech, NeuroTech, and Biohacking - Fundraising in 2020 and 2021 Wesley King
Market size and overview from health technology, wellness services, mental health applications, and telehealth solutions. Fundraising advice for first-time entrepreneurs. Call to action to VCs and Family Offices to consider investments in the next generation of impactful health devices. Wesley King @biohackingbanker CEO, Coherent Capital (www.coherentcap.com)
Top 10 companies using CRISPR technologyARUNPANDIAN07
The revolutionary gene editing tool CRISPR/Cas9 has reached its height because of its accuracy and easy-to-design. Several gene corrections have been made by scientists in vitro and in vivo.
For more information, visit, www.theblackchalk.com
Cell Therapy Industry News Round-Up - September 13, 2022 [BioInformant]BioInformant
The document discusses several topics related to stem cells and regenerative medicine:
1) It provides an overview of 10 scientists nominated for a $100,000 stem cell research grant to be awarded in October.
2) It describes a new collaboration between RoosterBio and AGC Biologics to accelerate manufacturing of cell and exosome therapies.
3) It announces that Steakholder Foods will begin developing cultured pork products using induced pluripotent stem cells.
Medical device companies are looking to emerging markets like India, China, Brazil and Russia for growth due to challenges in developed markets from the global financial crisis. The emerging markets offer major opportunities due to their growing economies, expanding middle class populations and increasing healthcare spending. However, to successfully launch devices in these markets, companies will need to understand the local market needs, create customized and affordable products for each market, develop new collaborative R&D networks to drive innovation, and partner with local players to better serve customers.
American CryoStem Corporation was founded in 2008 to standardize adipose tissue-derived stem cell technologies. It operates FDA-registered clinical laboratories in New Jersey, Hong Kong, and Japan. The company leverages its intellectual property portfolio and clinical platform to create a global network of licensed laboratories, physicians, patients, and researchers. Its products include adult stem cells derived from adipose tissue and characterized for regenerative medicine applications. The company focuses on collaborations to discover, develop, and commercialize new adipose-derived stem cell products and applications.
American CryoStem Corporation was founded in 2008 to standardize adipose tissue-derived stem cell technologies. It operates FDA-registered clinical laboratories in New Jersey, Hong Kong, and Japan. The company leverages its intellectual property portfolio and stem cell products to create a global network of licensed laboratories, physicians, patients, and researchers. Its research focuses on collaborations to discover, develop, and commercialize adipose-derived stem cell products and applications in regenerative medicine.
American CryoStem Corporation is a biotechnology company founded in 2008 that operates FDA-registered clinical laboratories. It has developed a proprietary platform and portfolio of intellectual property focused on collecting, processing, storing, and differentiating adipose tissue and adipose-derived stem cells for regenerative medicine applications. The company's products and services are aimed at allowing individuals to prepare for their current or future regenerative medicine needs by storing their stem cells when they are young and healthy.
An Opportunity for delegates to know how much they really know / need to know . The first person who answers a question correctly will get a prize. 30 Minutes of action
packed intellectual treat to find out the smartest !
AI – Opportunities and Challenges in Transforming the Biopharma Value ChainEY
These slides were presented by Pamela Spence, EY Global Life Sciences Industry Leader, at the annual BIO International Convention on 20 June 2017. Pamela led a panel discussion on Artificial Intelligence (AI) and the opportunities and challenges it presents in transforming the biopharma value chain. The panelists included Dr. Attul Butte, Director of the Institute for Computational Health Science at the University of California – San Francisco, Iya Khalil, Chief Commercial Officer and Co-founder of GNS Healthcare, Nathan Price, Associate Director of the Institute for Systems Biology and co-founder of Arivale, and Jackie Hunter, CEO of Benevolent AI
Life Sciences De-Mystified - Mark Bünger - PICNIC '10PICNIC Festival
This document provides an overview of synthetic biology and its potential applications presented by Mark Bünger of Lux Research. It begins with a brief introduction of Lux Research and their focus on emerging technologies. It then provides a high-level introduction to biology, including DNA, proteins, and how cells communicate. Applications of synthetic biology discussed include using biomass to replace petroleum products, standardizing biological parts for predictable circuits, and rapidly declining DNA sequencing costs enabling new products. Corporations, venture capital investment, and biohackers participating in synthetic biology are also mentioned. The document concludes by discussing participating in shaping the future of this emerging field through learning, action, and teaching.
5 companies in the wound healing market to watch for in 2019Avi Surana
The global wound healing market is projected to reach USD 42,069 million by 2024 growing at a CAGR of 6.2%, according to ResearchAndMarkets.com. North America is the largest market for wound care, with U.S alone taking a lion’s share of 38.5% in 2017 while Asia-Pacific is the fastest growing market.
We take a look at some of the companies that are developing novel technologies to address the unmet and growing needs of the wound care market.
ImmunoPrecise Antibodies Ltd (NASDAQ-IPA) Stock In Focus After Latest NewsThe Street Reports
If you are currently looking into artificial intelligence driven innovative companies then you could consider taking a look at ImmunoPrecise Antibodies Ltd (NASDAQ:IPA).
Dr. Jeanann Boyce gave a presentation on current issues in biotechnology and the ethical questions they raise. She discussed three areas: intelligent machines like robots and expert systems; disembodied and distributed intelligence on the internet; and human/machine interfaces like implants, prosthetics and cyborgs. She questioned where to draw the line between human and machine, and who would decide what kinds of part-human creatures or enhanced humans would be developed.
The document discusses various applications of artificial intelligence including in business, healthcare, robotics, and video games. It provides details on how AI is used in industries like online customer support, smart home devices, medical diagnosis and treatment, and remote-controlled or autonomous robots. Examples are given of AI systems developed by companies like Google, IBM, Amazon, and startups for applications such as predictive healthcare analytics, medical data mining, and assisting physicians.
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
Artificial intelligence in field of pharmacyKaustav Dey
AI is a program designed to produce outcome in a manner similar to human intelligence,logic and reasoning.This can be used in field of Pharmacy for betterment of humankind, to save lives,money and time
This document discusses investing in emerging healthcare technologies that could save lives in the future. It notes that diseases like kidney disease, influenza, diabetes, Alzheimer's, respiratory diseases, stroke and cancer caused over 3 million deaths in the US in 2020. The document then profiles several companies in Zoic Capital's portfolio that are developing technologies like Raman spectroscopy probes for cancer detection, retina scanning for early Alzheimer's detection, bioelectronic probes, RNA vaccines, at-home genetic testing, brain stimulation for mental health conditions, and more. It argues these emerging technologies could transform healthcare delivery by lowering costs, improving quality and access to care.
The document describes a decentralized smart collaborative IT platform that aims to become a collective human general intelligence, rather than an artificial general intelligence. It will harness expertise from around the world, regardless of nationality, and use ratings and voting to ensure objectivity. Experts will confirm the competence of start-up projects, and investors can find inexpensive expertise. The system was created by Deep Knowledge Ventures to access the best scientific ideas, and will become self-sufficient over time.
Artificial Intelligence Service in HealthcareAnkit Jain
It is no secret that artificial intelligence is shaping new business landscapes in every industries. As one of emerging convergence technologies, Artificial Intelligence (AI) creates new products and services, finally innovating business models. Especially, it has been noted by industry experts and researchers that healthcare sector has the biggest potential of AI convergence. In fact, major technology companies including Google, Microsoft and IBM have invested in AI in healthcare sector. Thousands of AI startups are active launching innovative services related to healthcare.
Quantitative + Qualitative = User Behavior Analytics
Introducing REAL User Behavior Analytics to your product team to better understand what and how users use your online/mobile applications.
7 Key Principles Designing for VUI/CUI
1. Onboarding the user & help them get started
2. Keep conversation exchanges brief to reduce cognitive load.
3. Examples work better than instructions.
4. Delight without interfering with the tasks.
5. Use explicit confirmation for important actions, & implicit for less risky.
6. Design for failure.
7. Respect the user's privacy and security.
What is Voice?
Why you should consider adding voice?
Voice: Pros vs Cons
Introducing Voice into your SDLC / PDLC
5 Steps to Designing for Voice Before Coding
7 Principles for Designing for Voice
Real Life Conditions
Voice AI Persona, Personality, Tone and Character
Resources, Tools, and More
@igotux
The Rise of Voice Invoca Report: Nov 2017Isidore Gotto
Voice assistants are becoming more widely used, changing how consumers learn about brands through voice search and interact with brands through voice apps. As voice technology improves, it is enabling new forms of customer acquisition, engagement, and support. Marketers must understand how voice interactions can enhance customer relationships and build voice experiences that connect to their digital strategies.
User Testing Webinar: Mobile Banking Industry Insights 02.21.2018Isidore Gotto
This document summarizes the findings of a study comparing the mobile banking experiences of Bank of America, Chase, and Wells Fargo. Key findings include:
1. Transferring money between accounts was the easiest task for all banks. Setting fraud alerts had the lowest ratings.
2. Bank of America had the top-rated overall experience and consistency. Finding statements was difficult in the Wells Fargo app.
3. All banks can improve navigation and labeling to make features easier to find. Meeting expectations is not enough - apps must delight users.
The document discusses predictions for 2018. Some key points:
1. Customer experience initiatives will plateau or decline for most companies, with 30% seeing further quality declines costing them a point of growth.
2. 20% of CEOs will fail to act on digital transformation, putting their firms at risk.
3. Talent shortages will widen the divide between digital leaders and laggards, with laggards paying up to 20% more to attract scarce skills.
4. Intelligent agents will directly influence 10% of purchase decisions as they gain a richer understanding of individual preferences and behaviors.
Answer lab best practices in research and design for voice user interfacesIsidore Gotto
The document discusses research conducted on smart speaker owners to understand usage patterns and opportunities for improvement. Some key findings include:
- Most owners are satisfied with their devices but many have experienced technical issues or frustrations.
- Third-party applications are confusing for many users and a significant portion have encountered problems.
- Brands need to ensure they deliver high-quality voice experiences or risk damaging their reputation.
- Best practices for voice application design include focusing on tasks that leverage voice strengths and reducing complexity.
Grow your business with the power of Graph Database. We take a look at how a social graph database could help legal professionals Grow their Legal Practice
User Experience Tools for the UX Professional Isidore Gotto
Being asked all the time on what tools do I use or recommend, I put together this list of common user experience tools that any UX professional should have in their toolbox.
Follow me @igotux
This document lists and provides links to numerous social media and technology events from 2011-2012. Some of the major events highlighted include the WEB 2.0 Expo, Blogwell Expo, CMX Expo, MIX conference, events from iirusa on social and web 2.0, and Internet Week NYC. The document also provides additional resources on social media marketing from MediaBistro and suggestions to subscribe to Mediapost and Microstrategy for more information. A variety of event topics are covered including social media, blogging, search marketing, user experience, and more.
Microsoft html5 web camp june 15 in nyc notesIsidore Gotto
The document summarizes the Microsoft HTML5 Web Camp that was held in NYC on June 15. It provides an overview of the topics covered, including HTML5 semantic markup, audio, video, canvas, geolocation, CSS3, SVG, ECMAScript5, and emerging standards. It also lists several references and tools that were recommended for HTML5 development.
"Choosing proper type of scaling", Olena SyrotaFwdays
Imagine an IoT processing system that is already quite mature and production-ready and for which client coverage is growing and scaling and performance aspects are life and death questions. The system has Redis, MongoDB, and stream processing based on ksqldb. In this talk, firstly, we will analyze scaling approaches and then select the proper ones for our system.
Skybuffer SAM4U tool for SAP license adoptionTatiana Kojar
Manage and optimize your license adoption and consumption with SAM4U, an SAP free customer software asset management tool.
SAM4U, an SAP complimentary software asset management tool for customers, delivers a detailed and well-structured overview of license inventory and usage with a user-friendly interface. We offer a hosted, cost-effective, and performance-optimized SAM4U setup in the Skybuffer Cloud environment. You retain ownership of the system and data, while we manage the ABAP 7.58 infrastructure, ensuring fixed Total Cost of Ownership (TCO) and exceptional services through the SAP Fiori interface.
What is an RPA CoE? Session 1 – CoE VisionDianaGray10
In the first session, we will review the organization's vision and how this has an impact on the COE Structure.
Topics covered:
• The role of a steering committee
• How do the organization’s priorities determine CoE Structure?
Speaker:
Chris Bolin, Senior Intelligent Automation Architect Anika Systems
Fueling AI with Great Data with Airbyte WebinarZilliz
This talk will focus on how to collect data from a variety of sources, leveraging this data for RAG and other GenAI use cases, and finally charting your course to productionalization.
Digital Banking in the Cloud: How Citizens Bank Unlocked Their MainframePrecisely
Inconsistent user experience and siloed data, high costs, and changing customer expectations – Citizens Bank was experiencing these challenges while it was attempting to deliver a superior digital banking experience for its clients. Its core banking applications run on the mainframe and Citizens was using legacy utilities to get the critical mainframe data to feed customer-facing channels, like call centers, web, and mobile. Ultimately, this led to higher operating costs (MIPS), delayed response times, and longer time to market.
Ever-changing customer expectations demand more modern digital experiences, and the bank needed to find a solution that could provide real-time data to its customer channels with low latency and operating costs. Join this session to learn how Citizens is leveraging Precisely to replicate mainframe data to its customer channels and deliver on their “modern digital bank” experiences.
[OReilly Superstream] Occupy the Space: A grassroots guide to engineering (an...Jason Yip
The typical problem in product engineering is not bad strategy, so much as “no strategy”. This leads to confusion, lack of motivation, and incoherent action. The next time you look for a strategy and find an empty space, instead of waiting for it to be filled, I will show you how to fill it in yourself. If you’re wrong, it forces a correction. If you’re right, it helps create focus. I’ll share how I’ve approached this in the past, both what works and lessons for what didn’t work so well.
Connector Corner: Seamlessly power UiPath Apps, GenAI with prebuilt connectorsDianaGray10
Join us to learn how UiPath Apps can directly and easily interact with prebuilt connectors via Integration Service--including Salesforce, ServiceNow, Open GenAI, and more.
The best part is you can achieve this without building a custom workflow! Say goodbye to the hassle of using separate automations to call APIs. By seamlessly integrating within App Studio, you can now easily streamline your workflow, while gaining direct access to our Connector Catalog of popular applications.
We’ll discuss and demo the benefits of UiPath Apps and connectors including:
Creating a compelling user experience for any software, without the limitations of APIs.
Accelerating the app creation process, saving time and effort
Enjoying high-performance CRUD (create, read, update, delete) operations, for
seamless data management.
Speakers:
Russell Alfeche, Technology Leader, RPA at qBotic and UiPath MVP
Charlie Greenberg, host
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/how-axelera-ai-uses-digital-compute-in-memory-to-deliver-fast-and-energy-efficient-computer-vision-a-presentation-from-axelera-ai/
Bram Verhoef, Head of Machine Learning at Axelera AI, presents the “How Axelera AI Uses Digital Compute-in-memory to Deliver Fast and Energy-efficient Computer Vision” tutorial at the May 2024 Embedded Vision Summit.
As artificial intelligence inference transitions from cloud environments to edge locations, computer vision applications achieve heightened responsiveness, reliability and privacy. This migration, however, introduces the challenge of operating within the stringent confines of resource constraints typical at the edge, including small form factors, low energy budgets and diminished memory and computational capacities. Axelera AI addresses these challenges through an innovative approach of performing digital computations within memory itself. This technique facilitates the realization of high-performance, energy-efficient and cost-effective computer vision capabilities at the thin and thick edge, extending the frontier of what is achievable with current technologies.
In this presentation, Verhoef unveils his company’s pioneering chip technology and demonstrates its capacity to deliver exceptional frames-per-second performance across a range of standard computer vision networks typical of applications in security, surveillance and the industrial sector. This shows that advanced computer vision can be accessible and efficient, even at the very edge of our technological ecosystem.
Introduction of Cybersecurity with OSS at Code Europe 2024Hiroshi SHIBATA
I develop the Ruby programming language, RubyGems, and Bundler, which are package managers for Ruby. Today, I will introduce how to enhance the security of your application using open-source software (OSS) examples from Ruby and RubyGems.
The first topic is CVE (Common Vulnerabilities and Exposures). I have published CVEs many times. But what exactly is a CVE? I'll provide a basic understanding of CVEs and explain how to detect and handle vulnerabilities in OSS.
Next, let's discuss package managers. Package managers play a critical role in the OSS ecosystem. I'll explain how to manage library dependencies in your application.
I'll share insights into how the Ruby and RubyGems core team works to keep our ecosystem safe. By the end of this talk, you'll have a better understanding of how to safeguard your code.
Discover top-tier mobile app development services, offering innovative solutions for iOS and Android. Enhance your business with custom, user-friendly mobile applications.
The Microsoft 365 Migration Tutorial For Beginner.pptxoperationspcvita
This presentation will help you understand the power of Microsoft 365. However, we have mentioned every productivity app included in Office 365. Additionally, we have suggested the migration situation related to Office 365 and how we can help you.
You can also read: https://www.systoolsgroup.com/updates/office-365-tenant-to-tenant-migration-step-by-step-complete-guide/
For the full video of this presentation, please visit: https://www.edge-ai-vision.com/2024/06/temporal-event-neural-networks-a-more-efficient-alternative-to-the-transformer-a-presentation-from-brainchip/
Chris Jones, Director of Product Management at BrainChip , presents the “Temporal Event Neural Networks: A More Efficient Alternative to the Transformer” tutorial at the May 2024 Embedded Vision Summit.
The expansion of AI services necessitates enhanced computational capabilities on edge devices. Temporal Event Neural Networks (TENNs), developed by BrainChip, represent a novel and highly efficient state-space network. TENNs demonstrate exceptional proficiency in handling multi-dimensional streaming data, facilitating advancements in object detection, action recognition, speech enhancement and language model/sequence generation. Through the utilization of polynomial-based continuous convolutions, TENNs streamline models, expedite training processes and significantly diminish memory requirements, achieving notable reductions of up to 50x in parameters and 5,000x in energy consumption compared to prevailing methodologies like transformers.
Integration with BrainChip’s Akida neuromorphic hardware IP further enhances TENNs’ capabilities, enabling the realization of highly capable, portable and passively cooled edge devices. This presentation delves into the technical innovations underlying TENNs, presents real-world benchmarks, and elucidates how this cutting-edge approach is positioned to revolutionize edge AI across diverse applications.
2. The technology market
intelligence platform.
CB Insights software lets you predict, discuss, and
communicate emerging technology trends using data
in ways that are beyond human cognition.
2
3. See what other customers have to say at http://www.cbinsights.com/customer-love
A FEW OF OUR HAPPY CUSTOMERS
The most publicly reference-able customers of anyone in the industry
Beti Cung, Corporate Strategy, Microsoft
“We use CB Insights to find emerging
trends and interesting companies that
might signal a shift in technology or
require us to reallocate resources.”
4. December 12 – 13, 2017 | San Francisco, CA
A-ha! is a gathering of Fortune 1000 executives, investors,
academics, and startup founders discussing the next wave of
ideas and technologies that will shape our world.
5. SPEAKERS INCLUDE
Daymond John
The Shark Group
Star of ABC’s Shark Tank
and CEO
FUBU
Founder/CEO
Liza Landsman
Jet.com
President
Sold to Walmart for $3.3B
Mudassir Sheikha
Careem
Co-founder & CEO
MENA’s $1.2B Unicorn
Benedict Evans
Andreessen Horowitz
Partner
“Working Out What’s
Happening Next” at a16z
7. Marc Andreessen
Andreessen Horowitz
7
"Most of the big breakthrough technologies
seem crazy at first... It has to be a radical
product. It has to be something where, when
people look at it, at first they say, I don’t get it, I
don't understand it…"
8. 8
Defining Game Changers
/ɡām - CHānjər/
noun
An event, idea, or procedure that effects a significant shift in
the current manner of doing or thinking about something.
A newly introduced element or factor that changes an
existing situation or activity in a significant way.
Our selected startups are high-momentum companies
pioneering technology with the potential to transform society
and economies for the better.
9. 9
2018 Game Changer categories
Neurotechnology Regenerative Medicine Synthetic Animal Products
Visualizing, improving, and
repairing brain functionality
3D printing and engineering organs,
cells, and tissues
Startups offering lab-grown animal
products from food to clothing
Synthetic Agriculture AI Chips Massive Simulations
Advanced technologies for
improving plant health and crop
yield
Startups developing processing
units for AI applications
The creation of simulated worlds
for predicting real-world outcomes
Intelligent Public Safety Autonomous Construction Rocket Launchers
The future of surveillance, crime
prevention, and emergency
response
Robotics and automation
equipment for the construction
industry
Startups re-inventing the way
rockets-to-space are built and
flown
Extreme Logistics
Delivery in places requiring tech to
compensate for lack of
infrastructure
10. Neurotechnology Regenerative Medicine Synthetic Animal Products
Synthetic Agriculture AI Chips Massive Simulations
Intelligent Public Safety Autonomous Construction Rocket Launchers
Extreme Logistics
10
2018 Game Changers
11. Most active investors in
game changers
Over 180 unique
investors backed this
year’s cohort of game
changers. Topping the
list was Andreessen
Horowitz, Data Collective,
IndieBio, NEA, Sequoia,
and SOSV, with
investments to 3 unique
game changers.
In total, 21 investors
backed 2 or more of
these companies.
With 20 backers, Zipline
International has the
most investors.
11
Top investors backing game-changing companies
Firms backing 2 or more unique game changer startups
14. Michael Tarr
Former co-director of Carnegie Mellon's
Center for the Neural Basis of Cognition
14
"The study of the mind and brain is the last frontier in
science. Although the field has made enormous
progress over the past several decades,
understanding of the basic principles of thought and
brain function are still far more unknown than
known.”
15. 15
BLOCK CHRONIC PAIN
Neuros Medical's technology delivers high-frequency stimulation to sensory nerves in the
peripheral nervous system to block chronic pain. The system consists of an electrode placed
around a peripheral nerve and is powered by an implantable pacemaker-size generator.
The company is focused on the elimination of chronic pain in a variety of conditions, including
amputation pain, post-surgical pain, migraine, and trigeminal neuralgia.
Select Investors: US Department of Defense, Boston Scientific Corporation, US Venture Partners
16. 16
Synchron is a medical device company developing an “endovascular neural interface” called the
Stentrode – an implantable brain device to achieve direct brain control of assisted technologies.
The technology platform is being developed to help paralyzed patients facilitate control of
external devices such as robotic limbs, computers, and exoskeletons by translating brain
activity into physical movement.
Select Investors: US Department of Defense, DARPA, Neurotechnology Investors
HELP PARALYZED PATIENTS
17. 17
PREVENT SEIZURES
NeuroPace offers an implantable device called the RNS System, for the treatment of
neurological disorders.
The company's initial focus is the treatment of epilepsy to prevent seizures. The device
recognizes electrical patterns specific to your brain, identifies unusual activity indicative of a
seizure and sends brief pulses to instantly normalize your brainwaves.
Select Investors: Johnson & Johnson Innovation, New Enterprise Associates, KPCB
19. 19
"This is going to be the future of medicine, where
stem cells and other types of cells can literally be the
treatment of devastating chronic and untreatable
diseases.”
Adeeb Al-Zoubi
Clinical Assistant Professor of Regenerative
Medicine at The University of Illinois
20. 20
PRINT ORGANS ON DEMAND
Prellis Biologics engineers human tissues and organs using laser-based 3D printing technology.
The company can create single layers of cells and build tissue scaffolds for organs on-demand
in a laboratory setting.
The company aims to address organ donor shortage and provide human tissues to streamline
the development of therapeutics. As its first product, Prellis Biologics is developing insulin-
secreting units of the pancreas to help people with Type 1 Diabetes.
Select Investors: True Ventures, SOSV, Civilization Ventures, 415 Ventures, IndieBio
21. 21
TRANSPLANT BETWEEN SPECIES
eGenesis is a life sciences company leveraging genome editing technology known as CRISPR
to deliver safe and effective human-transplantable cells, tissues and organs. The company is
developing a platform using xenotransplantation – the process of grafting or transplanting
organs or tissues between members of different species, primarily pigs.
eGenesis’ mission is to address the shortage of organs available for transplantation. The
company claims that using its technology, one animal can save an estimated eight lives.
Select Investors: Khosla Ventures, Alexandria Venture Investments, Uprising
22. 22
MANUFACTURE CELLS
BlueRock harnesses induced pluripotent stem cell (iPSC) therapies to use healthy cells to cure
a range of diseases. Using this Nobel Prize-winning technology, the company can
manufacture virtually unlimited quantities of pure healthy cells.
The company is initially targeting severe brain and heart conditions such as Parkinson’s
Disease and congestive heart failure.
Select Investors: Bayer, Versant Ventures
25. 25
REPLACE TRADITIONAL MEAT
Memphis Meats develops technology to engineer real meat without animals, by farming
animal stem cells in a lab without the need to feed, breed, and slaughter livestock.
The company claims its technology requires up to 90% less greenhouse gas emissions, land,
and water than conventionally produced meat. Scaling up for mass production, Memphis
Meats hopes its products will replace traditional meat altogether.
Select Investors: Bill Gates, Cargill, Richard Branson, Kimbal Musk, Draper Fisher Jurveston
$17M
26. 26
PRODUCE CULTURED LEATHER
Modern Meadow applies advances in tissue engineering to produce cultured leather that
requires no animal slaughter and much lower inputs of land, water, energy and chemicals than
conventional methods.
The process is called biofabrication. Starting with living cells, Modern Meadow can grow
collagen, the same natural protein found in animal skin, assemble it into a sheet of synthetic
leather, and then finish the aesthetics with a tanning process.
Select Investors: Sequoia Capital, ICONIQ Capital, Temasek Holdings, Tony Fadell
27. 27
HARVEST FISH STEM CELLS
Finless Foods is an early-stage biotechnology company that harvests fish stem cells from
living fish to produce lab-grown fish meat for human consumption.
The company’s goal is to make seafood more sustainable and healthier compared to today’s
conventionally caught and commercially farmed seafood.
Select Investors: IndieBio, SOSV
29. 29
By 2050, global demand for food
could increase up to 98%, and
synthetic agriculture could help
satisfy demand.
Source: Harvard Business Review / The Journal of the
International Association of Agricultural Economists
30. 30
NATURALLY PROMOTE PLANT HEALTH
Indigo Agriculture is developing microbial solutions to naturally promote plant health and
improve agricultural production. The company uses genomic sequencing and computational
bioinformatics to predict which microbes are most beneficial to plant health.
Indigo has built a platform for product discovery and generated a pipeline of candidates in
crops, including corn, soy, wheat, cotton and vegetables.
Select Investors: Flagship Pioneering, Baillie Gifford & Co., Alaska Permanent Fund, Activant
Capital Group
31. 31
IMPROVE CROP GENETICS
Benson Hill Biosystems leverages cloud biology, comprised of cloud computing, big data
analytics, and plant biology, to enable companies to improve crop genetics.
The company uses machine learning to predict which seeds will produce a desired trait. The
platform uses an array of tools, from breeding, to genome editing, to transgenics.
Select Investors: National Corn Growers Association, Alexandria Venture Investments
32. 32
CURE DISEASES IN CROPS
Inocucor offers a process that uses fermentation and microbe combinations to enable plants to reach
their full growth or yield potential. The process uses microbiological techniques to isolate individual
microbial strains based on their compatibility with one another and other factors.
The company has identified and field tested 11 microbial strains for use in farms and greenhouses, and
is currently working on biological formulas to cure diseases in crops such as strawberries, tomatoes,
and potatoes.
Select Investors: TPG Alternative & Renewable Technologies, Desjardins, Cycle Capital
34. AI is spreading across
industries
Interest in applying AI
across industries means
AI-enablement
companies are poised to
accelerate the future.
CB Insights Trends mines
a massive corpus of
media articles to enable a
data-driven, real-time
method to discover,
predict, and plot the arc
of rising expectations and
excitement for emerging
technologies.
34
Industry applications of AI coming into focus
2013 – 2017 YTD (11/14/2017)
Recent interest in industry
applications for AI, based on CB
Insights Trends Tool
35. 35
EXPLORE MACHINE INTELLIGENCE
Graphcore sells an intelligent processing unit (IPU) designed to lower the cost of AI applications in
cloud and enterprise data centers. The company offers a programming framework for research
teams and for customers working on commercial AI deployments.
Graphcore’s chips are reportedly up to 100 times faster than traditional processing units and
could someday help power the machine learning algorithms behind intelligent connected devices,
self-driving cars, and robotics.
Select Investors: Samsung Catalyst Fund, Dell Technologies Capital, Robert Bosch Capital
36. 36
PUT AI IN EVERYDAY DEVICES
Mythic offers a chip for enabling local AI, to turn everyday devices into intelligent systems
without leveraging the cloud. Mythic’s chips work in tandem with the company’s software to
make devices see, hear, and process the world. Target markets include smart home,
healthcare systems, and security and monitoring for commercial and home use, and drones
for industrial applications.
Mythic’s platform targets devices that previously lacked the computing power, battery life, and
reliable cloud connectivity to support decision making with AI.
Select Investors: Data Collective, AME Cloud Ventures, Lux Capital, Draper Fisher Jurveston
37. 37
SIMULATE HUMAN NERVE CELLS
Cambricon (寒武纪) is developing a brain-inspired processor chip that simulates human nerve
cells and synapses to conduct deep learning. The company’s chips can enable AI for computer
vision, autonomous driving and flying, security monitoring, speech recognition, and more.
Cambricon also offers an AI software platform for developers.
Cambricon says its chips double the performance of a conventional GPU while also
consuming less power.
Select Investors: Alibaba Entrepreneurs Fund, Lenovo Ventures Group, Yonghua Capital
39. 39
What are the advantages of massive simulations?
1.Make better
decisions
2.Introduce and test
variables
3.Examine edge
cases
4.Limit impact of
mistakes
40. 40
BUILD SIMULATED WORLDS
Improbable Worlds is developing an operating environment that allows user to build simulated
worlds that can be run in real time, simulating the behaviors and interactions of millions of
entities.
Improbable is focused on game development, but has implications for industries ranging from
commerce to security, enabling organizations to understand the consequences of their
choices before executing in the real world.
Select Investors: Temasek Holdings, Horizons Ventures, Andreessen Horowitz
41. 41
SIMULATE AGRICULTURAL OUTCOMES
CiBO Technologies is a sustainable agriculture company that simulates agricultural outcomes.
The company’s platform aggregates historical plant, soil, environmental, nutritional, and
ecological data to provide land-use simulations.
CiBO offers a distributed database for agronomically-relevant computations and analyses,
detailed weather simulations, and more.
Select Investors: Flagship Pioneering
42. 42
TEST AUTONOMOUS CARS
RightHook allows automotive, aviation, robotics, and other industries rapidly adopting
autonomous applications to safely test their products in simulated environments. The
company offers several products, including a suite for creating HD maps and traffic
simulations, as well as grid and cloud management for testing autonomous cars.
Because testing self-driving cars in the real world is potentially dangerous, further
development of autonomous technologies will rely on simulated test environments.
Select Investors: Tencent Holdings, First Round Capital, Fontinalis Partners
44. TSA airport security failed ‘in the
ballpark’ of 80 percent
November 9th, 2017
Public safety needs a tech makeover
44
45. 45
SECURE THE PERIMETER
Evolv Technology creates both hardware and software for physical security. The company
offers a security gate which can conduct rapid body scans of people without requiring them to
stop or slow down. The company's imaging sensor is designed to detect anomalies on a
person, like a bomb or firearms they may be trying to carry into a venue.
Evolv can also work with cameras and facial recognition software to identify people entering a
venue, and check them against relevant databases.
Select Investors: Gates Ventures, In-Q-Tel, General Catalyst, Data Collective
46. 46
EXPLORE HIGH THREAT ENVIRONMENTS
Shield AI builds artificially intelligent systems for protecting law enforcement officers,
emergency first responders, and civilians. The company offers a quadcopter that
autonomously explores high threat environments ahead of personnel and can also conduct
searches without a radio frequency link, be flown manually if needed, and learns and improves
over time.
Shield’s computer vision software works in conjunction with cameras and trained neural
networks to identify individuals, objects, and activities of interest.
Select Investors: Andreessen Horowitz, Homebrew
47. 47
DETECT VEHICULAR SECURITY THREATS
UVeye is building computer vision and machine learning technology to help detect vehicular
security threats. By scanning the undersides of passing vehicles, UVeye flags anomalies that
indicate a car has been modified for weaponization and/or smuggling.
UVeye’s under-vehicle inspection system leverages high-resolution 3D cameras and image
processing algorithms to identify car-housed explosives, concealed weapons, and other
contraband. License plate numbers can also be captured for database comparisons.
Select Investors: Ahaka Capital, SeedIL
49. 49
Shortage of manual labor in construction
Source: Forbes & Commercial Construction Index
50. 50
AUTOMATE EARTH MOVING
Built Robotics offers technology to automate earth moving and construction work. The
company is leveraging sensors from self-driving cars and retrofitting them into equipment for
the job site, as well as developing autonomous software designed specifically for construction
tasks related to excavating and grading for building foundations.
Solutions like those offered by Built could address a chronic labor shortage of construction
workers, boost productivity, and prevent work related injuries.
Select Investors: New Enterprise Associates, Great Oaks Venture Capital
51. 51
AUTOMATE MASONRY
Construction Robotics is developing hardware and software for the construction industry,
starting with SAM100, an autonomous bricklaying robot used for masonry. Combined with
SAM100, the company’s 3D brick-mapping software helps masons lay out wall designs and
account for onsite variations as well as capture real-time data for continuous improvements.
The company’s products aim to help masons be more productive, reduce repetitive-motion
injuries, and build more lasting buildings.
Select Investors: National Science Foundation under SBIR Phase I and II grants
52. 52
PRINT WHOLE BUILDINGS
Apis Cor is focused on making building construction fast, efficient, and high-quality by
delegating work to smart machines. The company offers a mobile construction 3D printer,
which prints buildings completely on site.
Apis’ mobile 3D building printer has made at least one house (within a single day) that the
company claims is durable enough to last up to 175 years.
Select Investors: Rusnano, Sistema
54. Nanosatellites are
taking off
According to estimates,
between 300 and 400
nano satellites (1 – 50kg)
will be launched
throughout 2018.
By 2022, approximately
2,500 additional nano
satellites will require
launch based on
announced plans and
programs.
54
55. 55
DELIVER SMALL SATELLITES
Rocket Lab is building an all carbon-composite launch vehicle. The rocket is designed for the
emerging small satellite market and can rapidly deliver small satellites to commercial orbits.
Rocket Lab is founded on the belief that small payloads require dedicated small launch
vehicles not currently offered by traditional rocket systems.
Select Investors: In-Q-Tel, Lockheed Martin, Khosla Ventures, Bessemer Venture Partners
56. 56
AUTOMATE ROCKET BUILDING
Relativity Space aims to build and fly rockets with zero human labor to resupply satellite
constellations. The company is creating what it calls an “evolvable product line” based around an
intelligent 3D printing manufacturing system. Relativity says the system can assemble a rocket
from scratch in 60 days with short lead times and at a low cost.
Relativity’s goal is to create the first rocket on Mars and ultimately lay the groundwork for building
industrial 3D printers that are lightweight and rugged enough to build a space colony.
Select Investors: Y Combinator, University of Southern CA, Stanford, Social Capital, Philip Spector
57. 57
DEVELOP SATELLITE MISSIONS
Kubos provides open source software and hardware for developing satellite missions. The
company offers developers building satellites an operating system, hardware support, and
developer tools for their missions. Products include cloud-based mission control software and
a test environment for flight hardware.
Kubos is focused on providing an operating system for small spacecraft. The company has
deals with three nanosatellite manufacturers: Pumpkin, NanoAvionics, and Innovative
Solutions in Space.
Select Investors: Entrenext Ventures, GGV Capital, Draper Dragon, Tim Draper
59. 59
“In developing countries, lack of
infrastructure is a far more serious
barrier to trade than tariffs.”
Joseph E. Stiglitz
Columbia University professor and recipient of
the Nobel Memorial Prize in Economic
Sciences (2001)
60. 60
USE UP EXCESS TRUCKING CAPACITY
CargoX is a logistics company that offers cargo transportation services for shippers in the
heavy duty trucking industry. The company’s machine learning technology is designed to use
up excess trucking capacity by triangulating trips and taking advantage of idle and return
spaces.
CargoX aims to cut down CO2 emissions and reduce the amount of empty trucks on the road.
The company is currently focusing on Brazil, where few railroads in the country mean that a
high proportion of the country’s freight gets shipped by trucks.
Select Investors: Goldman Sachs, Qualcomm Ventures, Soros Brothers Investments, Agility
61. 61
USE A PHONE AS AN ADDRESS
The Fetchr app aims to solve the logistical problem of lacking a physical address, which can
restrict the proliferation of delivery services, especially for ecommerce, in places like the Middle
East and North Africa, by allowing users to use a phone as a physical address.
Using Fetchr, drivers arrive to a customer's exact location via a phone to pick up a package and
deliver it to the recipient.
Select Investors: BECO Capital, Winklevoss Capital, Endeavor Catalyst, New Enterprise Associates
62. 62
GET BLOOD ON-DEMAND
Zipline International builds autonomous fixed-wing medical drones and runs airborne delivery
services, dropping medical supplies to clinics or hospitals in areas that aren't accessible by
land. The service lets health workers at remote clinics and hospitals text orders to Zipline for
on-demand medical products such as blood.
Zipline’s deliveries are often used for transfusions during surgeries or complicated childbirths,
or to treat victims of malaria. The company is operating in partnerships with the Rwandan and
Tanzanian governments.
Select Investors: Stanford University, Andreessen Horowitz, Google Ventures, Sequoia Capital
64. Game Changers annual
financing history
Year to date (11/13/17),
the 2018 Game Changer
startups have seen 31
deals worth nearly
$1.29B in funding.
At the current run rate,
2017 deals and dollars
are on track to reach a
high of 36 deals worth
nearly $1.5B, bringing
total disclosed equity
investment since 2013 to
over $2B and over 80
deals.
64
Fueling up for growth
2013 – 2017 YTD (11/13/17)
,
65. International game
changers
22 of the 30 game
changers are based in
the US or have moved to
the US.
However, 6 other
countries are home to
game changer
companies: Brazil,
Canada, China, Russia,
the UAE, and the UK.
65
Changing the world
30 companies headquartered in 7 countries
66. Game changers are
high-mosaic companies
CB Insights’ data-driven
Mosaic Money metric
assesses financial
signals including funding
recency, total amount
raised, and investor
quality to evaluate
private company health.
On average, our list of
game changers had
Mosaic Money scores
1.9x those of all tech
companies.
66
Mosaic money score comparison
Game Changers vs. all companies
67. 67
Game changers expert collection
Track all of the Game
Changer startups in this
presentation and many
more on our platform using
CB Insights’ Collections.
The expanded list of
startups includes high-
momentum companies
pioneering technology with
the potential to transform
society and economies for
the better.
68. 68
Our methodology
How the 10 categories were selected: We used the CB Insights Trends
tool, which mines and organizes millions of media articles to quantify
media attention to tech trends, to identify game changing tech trends.
How the 30 companies were selected: We used CB Insights Company
Mosaic, which tracks private company health using signals including
recency of financing, total raised, and investor quality, to identify high-
momentum/quickly growing companies within our categories. We’ve
gathered this data via our machine learning technology (dubbed The
Cruncher) as well as via several thousand direct submissions from
firms and individual professionals using The Editor.
The CB Insights Mosaic page walks through the factors considered in
the algorithm in greater detail.